Acadia’s Trofinetide Shows Efficacy In Rett Syndrome, But Safety Looks Shaky

 
• By Joseph Haas
  
Diagnosis Rett syndrome, pills and stethoscope.
Acadia's Phase III data could position trofinetide for first drug approval in Rett syndrome

More from Clinical Trials

More from R&D